Food and Bioprocess Technology

, Volume 3, Issue 3, pp 333–339 | Cite as

Health Benefits and Clinical Impact of Major Nutrient, Red Yeast Rice: A Review

  • M. KalaivaniEmail author
  • R. Sabitha
  • V. Kalaiselvan
  • A. Rajasekaran
Review Paper


Chinese red yeast rice (RYR), a natural food obtained after fermenting rice with Monascus purpureus. RYR contains unsaturated fatty acids, sterols, B-complex vitamins and monacolins with antioxidant properties. Scientific evidences showed that fermented RYR proved to be effective for the management of cholesterol, diabetes, cardiovascular disease (CVD) and also for the prevention of cancer. This review article describe about the usage of RYR in human being.


Red yeast rice Monascus purpureus Hypolipidemic Osteoporosis HMG-CoA reductase inhibitors 


  1. Agarwal, B., Halmo, B., Feoktistov, A. S., Protiva, P., Ramey, W. G., Chen, M., et al. (2002). Mechanism of lovastatin-induced apoptosis in intestinal epithelial cells. Carcinogenesis, 23, 521–528. doi: 10.1093/carcin/23.3.521.CrossRefGoogle Scholar
  2. Bau, Y. S. (1977). Pigmentation and antibacterial activity of fas neutron and X-ray induced strains of Monascus purpereus. Plant Physiology, 60, 578–581. doi: 10.1104/pp. 60.4.578.CrossRefGoogle Scholar
  3. Bibhu Prasad Panda, Saleem Javed, Mohammad Ali (2008) Optimization of fermentation parameters for higher lovastatin production in red mold rice through co-culture of Monascus purpureus and Monascus ruber. Food and bioprocess technology, doi: 10.1007/s 11947-008-0072-z
  4. Bobek, P., Ozdín, L., & Galbavý, S. (1998). Dose- and time-dependent hypocholesterolemic effect of oyster mushroom (Pleurotus ostreatus) in rats. Nutrition, 14(3), 282–286. doi: 10.1016/S0899-9007(97)00471-1.CrossRefGoogle Scholar
  5. Buchwald, H. (1992). Cholesterol inhibition, cancer, and chemotherapy. Lancet, 339, 1154–1156. doi: 10.1016/0140-6736(92) 90744-N.CrossRefGoogle Scholar
  6. Caruso, M. G., Notarnicola, M., Cavallini, A., & Di Leo, A. (2002). 3-Hydroxy-3-methylglutaryl coenzyme A reductase activity and low-density lipoprotein receptor expression in diffuse-type and intestinal-type human gastric cancer. Journal of Gastroenterology, 37, 504–508. doi: 10.1007/s005350200078.CrossRefGoogle Scholar
  7. Chang, J. C., Wu, M. C., Liu, I. M., & Cheng, J. T. (2006). Plasma glucose-lowering action of Hon-Chi in streptozotocin-induced diabetic rats. Hormone and Metabolic Research, 38(2), 76–81. doi: 10.1055/s-2006-925116.CrossRefGoogle Scholar
  8. Chen, F. C., Manchand, P. S., & Whalley, W. B. (1971). The chemistry of fungi: LXIV. The structure of monascin: the relative stereochemistry of the azaphilones. Journal of the Chemical Society, 21, 3577–3579.Google Scholar
  9. Chen, C.-C., & Liu, I.-M. (2006). Release of acetylcholine by Hon-Chi to raise insulin secretion in Wistar rats. Neurosci Lett, 404, 117–21. doi: 10.1016/j.neulet.2006.05.024.CrossRefGoogle Scholar
  10. Liao, C.-C., & Huang, C.-L. (2008). Red Yeast Rice for a patient with olanzapine-induced dyslipidemia: a test-and-retest case report. Prog Neuropsychopharmacol Biol Psychiatry, 32, 1340–1. doi: 10.1016/j.pnpbp.2008.02.014.CrossRefGoogle Scholar
  11. Endo, A., & Monacolin, K. (1980). A new hypocholesterolemic agent that specifically inhibits 3-hydroxy-3-methylglutaryl coenzyme A reductase. Journal of Antibiotics (Tokyo), 33930, 334–336.Google Scholar
  12. Fowell, A. D. G., Robertson, A., & Whalley, W. B. (1956). Monascorubramin. Journal of Chemical Society, 5, 27–35.Google Scholar
  13. Gavagan, T. (2002). Cardiovascular disease primary care, 29(2), 323–338.Google Scholar
  14. Hadfield, J. R., Holker, J. S. E., & Stanway, D. N. (1967). The biosynthesis of fungal metabolites: Part II. The β-oxo-lactone equivalences in rubropunctatin and monascorubrin. Journal of Chemical Society, 19, 751–755.Google Scholar
  15. Heber, D., Yip, I., Ashley, J. M., Elashoff, D. A., Elashoff, R. M., & Go, V. L. (1999). Cholesterol-lowering effects of a proprietary Chinese red yeast rice dietary supplement. American Journal of Clinical Nutrition, 69, 231–236.Google Scholar
  16. Heber, D., Lembertas, A., Lu, Q. Y., Bowerman, S., & Go, V. L. W. (2001). An analysis of nice proprietary Chinese Red Yeast Rice dietary supplements:implications of variability in chemical profile and contents. Journal of Alternative & Complementary Medicine, 7, 133–139. doi: 10.1089/107555301750164181.CrossRefGoogle Scholar
  17. Hentosh, P., Yuh, S. H., Elson, C. E., & Peffley, D. M. (2001). Sterol-independent regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in tumor cells. Molecular Carcinogenesis, 32, 154–166. doi: 10.1002/mc.1074.CrossRefGoogle Scholar
  18. Hong, M. Y., Seeram, N. P., Zhang, Y., & Heber, D. (2008). Anticancer effects of Chinese red yeast rice versus monacolin K alone on colon cancer cells. Journal of Nutritional Biochemistry, 19, 448–458.CrossRefGoogle Scholar
  19. Huang, C. F., Li, T. C., Lin, C. C., Liu, C. S., Shih, H. C., & Lai, M. M. (2007). Efficacy of Monascus purpureus Went rice on lowering lipid ratios in hypercholesterolemic patients. European J Cardiovasc Prev Rehabilation, 14(3), 438–440. doi: 10.1097/HJR.0b013e32801da137.CrossRefGoogle Scholar
  20. Huang, Z., Xu, Y., Li, L., & Li, Y. (2008). Two new Monascus metabolites with strong blue fluorescence isolated from red yeast rice. Journal of Agricultural and Food Chemistry, 56(1), 112–118. doi: 10.1021/jf072985a.CrossRefGoogle Scholar
  21. Jeon, T., Hwang, S. G., Hirai, S., Matsui, T., Yano, H., Kawada, T., et al. (2004). Red yeast rice extracts suppress adipogenesis by down- regulating adipogenic transcription factors and gene expression in 3T3-L1 cells. Life Sciences, 75(26), 3195–3203. doi: 10.1016/j.lfs.2004.06.012.CrossRefGoogle Scholar
  22. Journoud, M., & Jones, P. J. H. (2004). Red yeast rice: a new hypolipidemic drug. Life Sciences, 74, 2675–2683. doi: 10.1016/j.lfs.2003.10.018.CrossRefGoogle Scholar
  23. Kane, G. C., & Lipsky, J. J. (2000). Drug-grapefruit juice interactions. Mayo Clinic Proceedings, 75(9), 933–942. doi: 10.4065/75.9.933.CrossRefGoogle Scholar
  24. Keithley, J. K., Swanson, B., Sha, B. E., Zeller, J. M., Kessler, H. A., & Smith, K. Y. (2002). A pilot study of the safety and efficacy of cholestin in treating HIV-related dyslipidemia. Nutrition, 18(2), 201–204. doi: 10.1016/S0899-9007(01)00688-8.CrossRefGoogle Scholar
  25. Kim, C., Jung, H., Kim, Y. O., & Shin, C. S. (2006). Antimicrobial activities of amino acid derivatives of Monascus pigments. FEMS (Federation of European Microbiological Societies) Microbiology Letters, 264, 117–124. doi: 10.1111/j.1574-6968.2006.00451.x.CrossRefGoogle Scholar
  26. Kuromo, M., Nakanishi, K., Shindo, K., & Tada, M. (1963). Biosynthesis of monascorubrin and monascoflavin. Chemical Pharmaceutical Bulletin (Tokyo), 11, 358–362.Google Scholar
  27. Lee, C. L., Chen, W. P., Wang, J. J., & Pan, T. M. (2007a). A simple and rapid approach for removing citrinin while retaining monacolin K in red mold rice. Journal of Agricultural and Food Chemistry, 55(26), 11101–11108. doi: 10.1021/jf071640p.CrossRefGoogle Scholar
  28. Lee, C. L., Hung, H. K., Wang, J. J., & Pan, T. M. (2007b). Improving the ratio of monacolin K to citrinin production of Monascus purpureus NTU 568 under dioscorea medium through the mediation of pH value and ethanol addition. Journal of Agricultural and Food Chemistry, 55(16), 6493–6502. doi: 10.1021/jf0711946.CrossRefGoogle Scholar
  29. Lee, C. L., Kuo, T. F., Wang, J. J., & Pan, T. M. (2007c). Red mold rice ameliorates impairment of memory and learning ability in intracerebroventricular amyloid beta-infused rat by repressing amyloid beta accumulation. Journal of Neuroscience Research, 85(14), 3171–3182. doi: 10.1002/jnr.21428.CrossRefGoogle Scholar
  30. Lee, C. L., Tsai, T. Y., Wang, J. J., & Pan, T. M. (2006). In vivo hypolipidemic effects and safety of low dosage Monascus powder in a hamster model of hyperlipidemia. Applied Microbiology and Biotechnology, 705, 533–540. doi: 10.1007/s00253-005-0137-0.CrossRefGoogle Scholar
  31. Li, Z., Seeram, N. P., Lee, R., Thames, G., Minutti, C., Wang, H. J., et al. (2005). Plasma clearance of lovastatin versus Chinese red yeast rice in healthy volunteers. Journal of Alternative & Complementary Medicine, 11(6), 1031–1038. doi: 10.1089/acm.2005.11.1031.CrossRefGoogle Scholar
  32. Lin, C. C., Li, T. C., & Lai, M. M. (2005). Efficacy and safety of Monascus purpureus Went rice in subjects with hyperlipidemia. European Journal of Endocrinology, 153, 679–686. doi: 10.1530/eje.1.02012.CrossRefGoogle Scholar
  33. Lin, W. Y., Song, C. Y., & Pan, T. M. (2006). Proteomic analysis of Caco-2 cells treated with monacolin K. Journal of Agricultural and Food Chemistry, 54, 6192–6200. doi: 10.1021/jf061060c.CrossRefGoogle Scholar
  34. Lin, C. P., Chen, Y. H., Chen, J. W., Leu, H. B., Liu, T. Z., Liu, P. L., et al. (2008). Cholestin (Monascus purpureus rice) inhibits homocysteine- induced reactive oxygen species generation, nuclear factor- kappa B activation and vascular cell adhesion molecule-1 expression in human aortic endothelial cells. Journal of Biomedical Science, 15(2), 183–196. doi: 10.1007/s11373-007-9212-0.CrossRefGoogle Scholar
  35. Liu, L., Zhao, S. P., Cheng, Y. C., & Li, Y. L. (2003). Xuezhikang decreases serum lipoprotein(a) and C-reactive protein concentrations in patients with coronary heart disease. Clinical Chemistry, 49(8), 1347–1352. doi: 10.1373/49.8.1347.CrossRefGoogle Scholar
  36. Liu, J., Zhang, J., Shi, Y., Grimsgaard, S., Alraek, T., & Fonnebo, V. (2006). Chinese red yeast rice (Monascus purpureus) for primary hyperlipidemia:a meta-analysis of randomized controlled trials. Chinese Medicine, 1, 4.CrossRefGoogle Scholar
  37. Ma, J., Li, Y., Ye, Q., Li, J., & Hua, Y. (2000). Constituents of red yeast rice, a traditional Chinese food and medicine. Journal of Agricultural and Food Chemistry, 48(11), 5220–5225. doi: 10.1021/jf000338c.CrossRefGoogle Scholar
  38. Man, R. Y., Lynn, E. G., Cheung, F., & Tsang, P. S. (2002). Cholestin inhibits cholesterol synthesis and secretion in hepatic cells (HepG2). Molecular and Cellular Biochemistry, 233(1–2), 153–158.CrossRefGoogle Scholar
  39. Manchand, P. S., Whally, W. B., & Chen, F. C. (1973). Isolation and structure of ankaflavin. Phytochemistry, 12, 2531–2532. doi: 10.1016/0031-9422(73) 80470-4.CrossRefGoogle Scholar
  40. Martinkova, L., Patakova-Juzlova, P., Krent, V., Kucerova, Z., Havlicek, V., & Olsovsky, P. (1999). Biological activities of oligoketide pigments of Monascus purpureus. Food Additives and Contaminants, 16, 15–24. doi: 10.1080/026520399284280.CrossRefGoogle Scholar
  41. Moghadasian, M. H., & Frohlich, J. J. (1999). Effects of dietary phytosterols on cholesterol metabolism and atherosclerosis: clinical and experimental evidence. American Journal of Medicine, 107(6), 588–594. doi: 10.1016/S0002-9343(99)00285-5.CrossRefGoogle Scholar
  42. Mueller, P. S. (2006). Symptomatic myopathy due to red yeast rice. Annals of Internal Medicine, 145, 474–475.Google Scholar
  43. Notarnicola, M., Messa, C., Pricci, M., Guerra, V., Altomare, D. F., Montemurro, S., et al. (2004). Up-regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in left-sided human colon cancer. Anticancer Research, 24, 3837–3842.Google Scholar
  44. Palo, M. A., Vidal-Adeva, L., Maceda, L. M. (1960). A study on ang-kak and its production. Philippine Journal of Science, 89, 1–19.Google Scholar
  45. Plat, J., & Mensink, R. P. (2001). Effects of plant sterols and stanols on lipid metabolism and cardiovascular risk. Nutrition and Metabolism Cardiovascular Diseases, 11(1), 31–40.Google Scholar
  46. Poynter, J. N., Gruber, S. B., Higgins, P. D., Almog, R., Bonner, J. D., & Rennert, H. S. (2005). Statins and the risk of colorectal cancer. New England Journal of Medicine, 352, 2184–2192. doi: 10.1056/NEJMoa043792.CrossRefGoogle Scholar
  47. Prasad, G. V., Wong, T., Meliton, G., & Bhaloo, S. (2002). Rhabdomyolysis due to red Yeast rice (Monascus purpureus) in a renal transplant recipient. Transplantation., 74, 1200–1201. doi: 10.1097/00007890-200210270-00028.CrossRefGoogle Scholar
  48. Qin, S., Zhang, W., Qi, P., Zhao, M., Dong, Z., Li, Y., et al. (1998). Taxonomic investigation of Monascus purpureus 94–25 strain. Journal of Culture Collections, 2, 1997–1998.Google Scholar
  49. Ricky, W. K., & Bakr, R. (2008). Chinese red yeast rice (Monascus pupureus fermented-rice) promotes bone formation. Chinese Medicine, 3, 4. doi: 10.1186/1749-8546-3-4.CrossRefGoogle Scholar
  50. Smith, D. J., & Olive, K. E. (2003). Chinese red rice-induced myopathy. Southern Medical Journal, 96, 1265–1267. doi: 10.1097/01.SMJ.0000100117.79718.DC.CrossRefGoogle Scholar
  51. Ukomadu, C., & Dutta, A. (2003). p21-dependent inhibition of colon cancer cell growth by mevastatin is independent of inhibition of G1 cyclindependent kinases. Journal of Biological Chemistry, 278, 43586–43594. doi: 10.1074/jbc.M307194200.CrossRefGoogle Scholar
  52. Venkateshwar, R., Polsani, M. D., Peter, H., Jones, M. D., Christie, M., Ballantyne, M. D., et al. (2008). A case report of myopathy from consumption of red yeast rice. Journal of Clinical Lipidology, 2, 60–62. doi: 10.1016/j.jacl.2007.12.005.CrossRefGoogle Scholar
  53. Vercelli, L., Mongini, T., Olivero, N., Rodolico, C., Musumeci, O., & Palmucci, L. (2006). Chinese red rice depletes muscle coenzyme Q10 and maintains muscle damage after discontinuation of statin treatment. Journal of the American Geriatrics Society, 54(4), 718–720. doi: 10.1111/j.1532-5415.2006.00668_7.x.CrossRefGoogle Scholar
  54. Wang, T. H., & Lin, T. F. (2007). Monascus Rice products. Advances in Food and Nutrition Research, 53, 123–159. doi: 10.1016/S1043-4526(07) 53004-4.CrossRefGoogle Scholar
  55. Wang, J., Lu, Z., Chi, J., Wang, W., Su, M., Kou, W., et al. (1997). Multicenter clinical trial of the serum lipid-lowering effects of a monascus purpureus (red yeast) rice preparation from traditional Chinese medicine. Current Therapeutic Research, 58(12), 964–978. doi: 10.1016/S0011-393X(97)80063-X.CrossRefGoogle Scholar
  56. Wang, W. H., Zhang, H., Yu, Y. L., Ge, Z., Xue, C., & Zhang, P. (2004). Intervention of xuezhikang on patients of acute coronary syndrome with different levels of blood lipids. Zhongguo Zhong Xi Yi Jie He Za Zhi, 24(12), 1073–1076.Google Scholar
  57. Wei, W., Li, C., Wang, Y., Su, H., Zhu, J., & Kritchevsky, D. (2003). Hypolipidemic and anti-atherogenic effects of long-term Cholestin (Monascus purpureus-fermented rice, red yeast rice) in cholesterol fed rabbits. Journal of Nutritional Biochemistry, 14(6), 314–318. doi: 10.1016/S0955-2863(03)00051-2.CrossRefGoogle Scholar
  58. Wild, D., Toth, G., & Humpf, H. U. (2002). New monascus metabolite isolated from red yeast rice (angkak, red koji). Journal of Agricultural and Food Chemistry, 14, 3999–4002. doi: 10.1021/jf020023s.CrossRefGoogle Scholar
  59. Wong, H. C., & Bau, Y. S. (1977). Pigmentation and antibacterial activity of fast neutron and X-ray induced strains of Monascus purpureus Went. Plant Physiology, 60, 578–581. doi: 10.1104/pp. 60.4.578.CrossRefGoogle Scholar
  60. Wong, H. C., & Koehler, P. E. (1981). Production and isolation of an antibiotic from Monascus purpureus and its relationship to pigment production. Journal of Food Science, 46, 589–592. doi: 10.1111/j.1365-2621.1981.tb04917.x.CrossRefGoogle Scholar
  61. Yasukawa, K., Takahashi, M., Natori, S., Kawai, K., Yamazaki, M., Takeuchi, M., et al. (1994). Azaphilones inhibit tumor promotion by 12-O-tetradecanoylphorbol- 13-acetate in two-stage carcinogenesis in mice. Oncology, 51, 108–112.CrossRefGoogle Scholar
  62. Yasukawa, K., Takahashi, M., Yamanouchi, S., & Takido, M. (1996). Inhibitory effect of oral administration of Monascus pigment on tumor promotion in two-stage carcinogenesis in mouse skin. Oncology, 53, 247–249.CrossRefGoogle Scholar
  63. Yong-Guo, L. I., Zhang, F., Zheng-Tao, W., & Zhi-Bi, H. (2004). Identification and chemical profiling of monacolins in red yeast rice using high-performance liquid chromatography with photodiode array detector and mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis, 35, 1101–1112. doi: 10.1016/j.jpba.2004.04.004.CrossRefGoogle Scholar
  64. Zhao, S. P., Liu, L., Cheng, Y. C., & Li, Y. L. (2003). Effect of xuezhikang, a cholestin extract, on reflecting postprandial triglyceridemia after a high-fat meal in patients with coronary heart disease. Atherosclerosis, 168(2), 375–380. doi: 10.1016/S0021-9150(03)00142-4.CrossRefGoogle Scholar
  65. Zhao, S. P., Liu, L., Cheng, Y. C., Shishehbor, M. H., Liu, M. H., Peng, D. Q., et al. (2004). Xuezhikang, an extract of cholestin, protects endothelial function through antiinflammatory and lipid-lowering mechanisms in patients with coronary heart disease. Circulation, 110(8), 915–920. doi: 10.1161/01.CIR.0000139985.81163.CE.CrossRefGoogle Scholar

Copyright information

© Springer Science + Business Media, LLC 2009

Authors and Affiliations

  • M. Kalaivani
    • 1
    Email author
  • R. Sabitha
    • 1
  • V. Kalaiselvan
    • 1
  • A. Rajasekaran
    • 1
  1. 1.Department of Pharmaceutical BiotechnologyKMCH College of PharmacyCoimbatoreIndia

Personalised recommendations